Harmine activates intrinsic and extrinsic pathways of apoptosis in B16F-10 melanoma

Chinese Medicine

Volumn 6, Issue , 2011, Pages

  Hamsa, Thayele P ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; HARMINE; PEGANUM HARMALA EXTRACT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; PROTEIN P53; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA FRAGMENTATION; DOWN REGULATION; FLOW CYTOMETRY; IN VITRO STUDY; INFLAMMATION; MELANOMA B16; METASTASIS; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 79953115220     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-6-11     Document Type: Article

References (38)

1. Pradelli LA, Beneteau M, Ricci JE. Mitochondrial control of caspase-dependent and -independent cell death. Cell Mol Life Sci 2010, 67:1589-1597. 10.1007/s00018-010-0285-y, 20151314.
2. Van Herreweghe F, Festjens N, Declercq W, Vandenabeele P. Tumor necrosis factor-mediated cell death: to break or to burst, that's the question. Cell Mol Life Sci 2010, 67:1567-1579. 10.1007/s00018-010-0283-0, 20198502.
3. Li-Weber M. Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Lett 2010,
4. Gyrd-Hansen M, Meier P. IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 2010, 10:561-574. 10.1038/nrc2889, 20651737.
5. Billen LP, Shamas-Din A, Andrews DW. Bid: a Bax-like BH3 protein. Oncogene 2008, 27(Suppl 1):S93-104. 10.1038/onc.2009.47, 19641510.
6. Hockenbery DM. Targeting mitochondria for cancer therapy. Environ Mol Mutagen 2010, 51:476-489. 10.1002/em.20552, 20213841.
7. Farnebo M, Bykov VJ, Wiman KG. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun 2010, 396:85-89. 10.1016/j.bbrc.2010.02.152, 20494116.
8. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004, 10:789-799. 10.1038/nm1087, 15286780.
9. Dutta J, Fan Y, Gupta N, Fan G, Gélinas C. Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 2006, 25(51):6800-6816. 10.1038/sj.onc.1209938, 17072329.
10. Ghosh CC, Ramaswami S, Juvekar A, Vu HY, Galdieri L, Davidson D, Vancurova I. Gene-Specific Repression of Proinflammatory Cytokines in Stimulated Human Macrophages by Nuclear I{kappa}B{alpha}. J Immunol 2010, 185:3685-3693. 10.4049/jimmunol.0902230, 20696864.
11. Persengiev SP, Green MR. The role of ATF/CREB family members in cell growth, survival and apoptosis. Apoptosis 2003, 8:225-228. 10.1023/A:1023633704132, 12766482.
12. Bhoumik A, Huang TG, Ivanov V, Gangi L, Qiao RF, Woo SL, Chen SH, Ronai Z. An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 2002, 110:643-650. 151112, 12208865.
13. Muscella A, Urso L, Calabriso N, Vetrugno C, Rochira A, Storelli C, Marsigliante S. Anti-apoptotic effects of protein kinase C-delta and c-fos in cisplatin-treated thyroid cells. Br J Pharmacol 2009, 156:751-763. 10.1111/j.1476-5381.2008.00049.x, 2697754, 19254279.
14. Ivanov VN, Ronai Z. Down-regulation of tumor necrosis factor alpha expression by activating transcription factor 2 increases UVC-induced apoptosis of late-stage melanoma cells. J Biol Chem 1999, 274:14079-14089. 10.1074/jbc.274.20.14079, 10318823.
15. Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V. The role of ATF-2 in oncogenesis. Bioessays 2008, 30:314-327. 10.1002/bies.20734, 18348191.
16. Aggarwal S, Kim SW, Ryu SH, Chung WC, Koo JS. Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein. Cancer Res 2008, 68:981-988. 10.1158/0008-5472.CAN-06-0249, 2921320, 18281471.
17. Cao R, Chen Q, Hou X, Chen H, Guan H, Ma Y, Peng W, Xu A. Synthesis, acute toxicities, and antitumor effects of novel 9-substituted beta-carboline derivatives. Bioorg Med Chem 2004, 12:4613-4623. 10.1016/j.bmc.2004.06.038, 15358288.
18. Murray TD, Berger A. Alcohol withdrawal. Va Med Q 1997, 124:184-187. 189.
19. Perez Martin JM, Labrador V, Fernandez Freire P, Molero ML, Hazen MJ. Ultrastructural changes induced in HeLa cells after phototoxic treatment with harmine. J Appl Toxicol 2004, 24:197-201. 10.1002/jat.972, 15211613.
20. Chen Q, Chao R, Chen H, Hou X, Yan H, Zhou S, Peng W, Xu A. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis. Int J Cancer 2005, 114:675-682. 10.1002/ijc.20703, 15609303.
21. Abe A, Yamada H. Harmol induces apoptosis by caspase-8 activation independently of Fas/Fas ligand interaction in human lung carcinoma H596 cells. Anticancer Drugs 2009, 20:373-381. 10.1097/CAD.0b013e32832a2dd9, 19318910.
22. Cole SP. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol 1986, 17:259-263. 10.1007/BF00256695, 3742711.
23. Chomczynski P, Sacchi N. Single-step method for RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159. 10.1016/0003-2697(87)90021-2, 2440339.
24. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983, 11:1475-1489. 10.1093/nar/11.5.1475, 325809, 6828386.
25. Evan G, Littlewood T. A matter of life and cell death. Science 1998, 281:1317-1322. 10.1126/science.281.5381.1317, 9721090.
26. Kressel M, Groscurth P. Distinction of apoptotic and necrotic cell death by in situ labelling of fragmented DNA. Cell Tissue Res 1994, 278:549-556. 10.1007/BF00331373, 7850865.
27. Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 2000, 12:85-98. 10.1006/smim.2000.0210, 10723801.
28. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292:727-730. 10.1126/science.1059108, 3049805, 11326099.
29. Chipuk JE, Green DR. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?. Trends Cell Biol 2008, 18:157-164. 10.1016/j.tcb.2008.01.007, 18314333.
30. Luo W, Liu J, Li J, Zhang D, Liu M, Addo JK, Patil S, Zhang L, Yu J, Buolamwini JK, Chen J, Huang C. Anti-cancer effects of JKA97 are associated with its induction of cell apoptosis via a Bax-dependent and p53-independent pathway. J Biol Chem 2008, 283:8624-8633. 10.1074/jbc.M707860200, 2417161, 18218619.
31. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 2000, 345(Pt 2):271-278. 10.1042/0264-6021:3450271, 1220756, 10620504.
32. Ooi KL, Tengku Muhammad TS, Lim CH, Sulaiman SF. Apoptotic effects of Physalis minima L. chloroform extract in human breast carcinoma T-47D cells mediated by c-myc-, p53-, and caspase-3-dependent pathways. Integr Cancer Ther 2010, 9:73-83. 10.1177/1534735409356443, 20150224.
33. Cheng JD, Werness BA, Babb JS, Meropol NJ. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma. Clin Cancer Res 1999, 5:1057-1062.
34. Megha T, Lazzi S, Ferrari F, Vatti R, Howard CM, Cevenini G, Leoncini L, Luzi P, Giordano A, Tosi P. Expression of the G2-M checkpoint regulators cyclin B1 and P34CDC2 in breast cancer: a correlation with cellular kinetics. Anticancer Res 1999, 19:163-169.
35. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009, 1:a001651. 10.1101/cshperspect.a001651, 20457564.
36. Piotrowska A, Izykowska I, Podhorska-Okolow M, Zabel M, Dziegiel P. The structure of NF- kappaB family proteins and their role in apoptosis. Postepy Hig Med Dosw 2008, 62:64-74.
37. Choi HS, Kang BS, Shim JH, Cho YY, Choi BY, Bode AM, Dong Z. Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity. FASEB J 2008, 22:113-126. 10.1096/fj.07-9078com, 2822465, 17724252.
38. Xiao L, Rao JN, Zou T, Liu L, Marasa BS, Chen J, Turner DJ, Zhou H, Gorospe M, Wang JY. Polyamines regulate the stability of activating transcription factor-2 mRNA through RNA-binding protein HuR in intestinal epithelial cells. Mol Biol Cell 2007, 18:4579-4590. 10.1091/mbc.E07-07-0675, 2043536, 17804813.